Clinical Cancer Research Bridging the Lab and the Clinic in Cancer Medicine
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Maxwell, G. L.
Right arrow Articles by Berchuck, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Maxwell, G. L.
Right arrow Articles by Berchuck, A.
Clinical Cancer Research Vol. 6, 2999-3005, August 2000
© 2000 American Association for Cancer Research


Advances in Brief

Racial Disparity in the Frequency of PTEN Mutations, but not Microsatellite Instability, in Advanced Endometrial Cancers

G. Larry Maxwell, John I. Risinger, Kate A. Hayes, Angeles A. Alvarez, Richard K. Dodge, J. Carl Barrett and Andrew Berchuck1

Departments of Obstetrics and Gynecology/Division of Gynecologic Oncology [G. L. M., A. A. A., A. B.] and Biostatistics [R. K. D.], Duke University Medical Center, Durham, North Carolina 27710, and Laboratory of Molecular Carcinogenesis, National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina 27709 [J. I. R., K. A. H., J. C. B.]

Survival of African Americans with endometrial cancer is significantly worse than that of whites. Mutation of the PTEN tumor suppressor gene and microsatellite instability occur in some endometrial cancers, and they are associated with favorable prognostic features. The aim of this study was to determine whether there is a racial disparity in the frequency of these molecular alterations that contributes to differences in outcome in advanced endometrial cancer.

We screened 140 stage III/IV endometrial adenocarcinomas (78 Caucasian, 62 African American) for mutations in the PTEN gene. Paired DNA samples were available in 100 cases and were analyzed for microsatellite instability using three polymorphic markers.

African-American women had cancers with significantly higher stage and grade that were more often nonendometrioid. In addition, median survival of African Americans (1.0 years) was worse than that of whites (2.5 years; P = 0.02). PTEN mutation was seen in 20 of 140 (14%) cancers and was associated with endometrioid histology and more favorable survival. The frequency of PTEN mutations was significantly higher in whites (17 of 78; 22%) than in African Americans (3 of 62; 5%; P = 0.006). Microsatellite instability was found in 15% of cancers, exclusively in endometrioid cases, and was associated with favorable survival (P = 0.01). There was no racial difference in the frequency of microsatellite instability.

We conclude that mutation of the PTEN tumor suppressor gene is associated with favorable survival in advanced endometrial cancer and is 4-fold more frequent in Caucasians relative to African Americans. This suggests that differences in the frequency of PTEN mutations contribute to the racial disparity in endometrial cancer survival.




This article has been cited by other articles:


Home page
Clin. Cancer Res.Home page
G. L. Maxwell, G.V.R. Chandramouli, L. Dainty, T. J. Litzi, A. Berchuck, J. C. Barrett, and J. I. Risinger
Microarray Analysis of Endometrial Carcinomas and Mixed Mullerian Tumors Reveals Distinct Gene Expression Profiles Associated with Different Histologic Types of Uterine Cancer
Clin. Cancer Res., June 1, 2005; 11(11): 4056 - 4066.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
T. C. Randall and K. Armstrong
Differences in Treatment and Outcome Between African-American and White Women With Endometrial Cancer
J. Clin. Oncol., November 15, 2003; 21(22): 4200 - 4206.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
R. P. Ermoian, C. S. Furniss, K. R. Lamborn, D. Basila, M. S. Berger, A. R. Gottschalk, M. K. Nicholas, D. Stokoe, and D. A. Haas-Kogan
Dysregulation of PTEN and Protein Kinase B Is Associated with Glioma Histology and Patient Survival
Clin. Cancer Res., May 1, 2002; 8(5): 1100 - 1106.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
T. Minaguchi, H. Yoshikawa, K. Oda, T. Ishino, T. Yasugi, T. Onda, S. Nakagawa, K. Matsumoto, K. Kawana, and Y. Taketani
PTEN Mutation Located Only Outside Exons 5, 6, and 7 Is an Independent Predictor of Favorable Survival in Endometrial Carcinomas
Clin. Cancer Res., September 1, 2001; 7(9): 2636 - 2642.
[Abstract] [Full Text] [PDF]


Home page
Obstet GynecolHome page
G. L. MAXWELL, J. I. RISINGER, A. A. ALVAREZ, J. C. BARRETT, and A. BERCHUCK
Favorable Survival Associated With Microsatellite Instability in Endometrioid Endometrial Cancers
Obstet. Gynecol., March 1, 2001; 97(3): 417 - 422.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2000 by the American Association for Cancer Research.